Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer

ClinicalTrials.gov ID: NCT00040807

Public ClinicalTrials.gov record NCT00040807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial Of Weekly Irinotecan And Docetaxel In Recurrent Or Metastatic Head And Neck Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of irinotecan and docetaxel in treating patients who have metastatic or locally recurrent head and neck cancer.

Study identification

NCT ID
NCT00040807
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 19, 2002 (Actual)
Primary completion
Apr 2005 (Actual)
Completion
May 1, 2009 (Actual)
Last update posted
Jun 18, 2023

2002 – 2009

United States locations

U.S. sites
43
U.S. states
21
U.S. cities
36
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300 —
Stanford Cancer Center at Stanford University Medical Center Stanford California 94305-5216 —
Medical Center of Aurora - South Campus Aurora Colorado 80012-0000 —
Boulder Community Hospital Boulder Colorado 80301-9019 —
Penrose Cancer Center Colorado Springs Colorado 80933 —
Porter Adventist Hospital Denver Colorado 80210 —
St. Joseph Hospital Denver Colorado 80218-1191 —
Presbyterian - St. Luke's Medical Center Denver Colorado 80218 —
Rocky Mountain Cancer Centers - Denver Rose Denver Colorado 80220 —
CCOP - Colorado Cancer Research Program, Incorporated Denver Colorado 80224 —
Swedish Medical Center Englewood Colorado 80112 —
Sky Ridge Medical Center Lone Tree Colorado 80124 —
Hope Cancer Care Center at Longmont United Hospital Longmont Colorado 80501 —
St. Mary-Corwin Regional Medical Center Pueblo Colorado 81004 —
Rocky Mountain Cancer Centers - Thornton Thornton Colorado 80221 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612-9497 —
Veterans Affairs Medical Center - Atlanta (Decatur) Decatur Georgia 30033 —
Veterans Affairs Medical Center - Lakeside Chicago Chicago Illinois 60611-4494 —
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611 —
CCOP - Evanston Evanston Illinois 60201 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61615-7828 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016 —
CCOP - Wichita Wichita Kansas 67214-3882 —
MBCCOP - LSU Health Sciences Center New Orleans Louisiana 70112 —
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 —
Tufts - New England Medical Center Boston Massachusetts 02111 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CCOP - Southern Nevada Cancer Research Foundation Las Vegas Nevada 89106 —
CCOP - Northern New Jersey Hackensack New Jersey 07601 —
Albert Einstein Clinical Cancer Center The Bronx New York 10461 —
MBCCOP-Our Lady of Mercy Cancer Center The Bronx New York 10466 —
CCOP - Toledo Community Hospital Toledo Ohio 43623-3456 —
CCOP - Oklahoma Tulsa Oklahoma 74136 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57104 —
CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay Wisconsin 54307-3453 —
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53792-0001 —
CCOP - Marshfield Clinic Research Foundation Marshfield Wisconsin 54449 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226-3596 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00040807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 18, 2023 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00040807 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →